TCM
GBT

Towercrest Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Towercrest Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,000
Closed -$205K – 76
2018
Q4 		$205K Buy
+5,000
New +$205K 0.07% 67